AM

Anil Manohar

Active Director Director DIN 00383517
DIN 00383517 First appointment Jul 2000 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2000
Shareholding value •••• Premium profile

About Anil Manohar

Data last updated:

Anil Manohar is a Director at Tarun Pharma Private Limited (since 2000). The company operates in Chemicals. Tarun Pharma Private Limited reported revenue of ₹12 Lakh (FY 2025).

DIN 00383517
Primary Designation Director
Industry Chemicals
First Appointment 14 Jul 2000
Oldest Company Age 26 yrs
Largest company Tarun Pharma Private Limited · ₹12 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tarun Pharma Private Limited U24231UP2000PTC025527
Director14 Jul 20002000₹12 Lakh (FY 2025)Active

Board colleagues of Anil Manohar

NameDINCompanyDesignation
Tarun Manohar00476823Tarun Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tarun Pharma Private Limited
Premium access

Shareholding and investment profile for Anil Manohar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Manohar

Anil Manohar currently holds 1 directorship: Tarun Pharma Private Limited (Director, since 14 Jul 2000, revenue ₹12 Lakh (FY 2025)).

Anil Manohar was first appointed on 14 Jul 2000 as Director at Tarun Pharma Private Limited.

The current boards of Anil Manohar's companies include Tarun Manohar (Tarun Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available